Ashford Capital Management Inc. Sells 189,585 Shares of Quanterix Co. (NASDAQ:QTRX)

Ashford Capital Management Inc. lessened its holdings in shares of Quanterix Co. (NASDAQ:QTRX) by 25.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 544,530 shares of the company’s stock after selling 189,585 shares during the quarter. Ashford Capital Management Inc. owned 1.41% of Quanterix worth $5,788,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of the business. JPMorgan Chase & Co. grew its holdings in shares of Quanterix by 23.9% during the fourth quarter. JPMorgan Chase & Co. now owns 270,054 shares of the company’s stock valued at $2,871,000 after buying an additional 52,097 shares during the last quarter. Raymond James Financial Inc. acquired a new position in Quanterix during the 4th quarter valued at about $570,000. Barclays PLC increased its holdings in Quanterix by 42.3% during the 3rd quarter. Barclays PLC now owns 146,248 shares of the company’s stock worth $1,896,000 after purchasing an additional 43,447 shares in the last quarter. Tower Research Capital LLC TRC raised its stake in shares of Quanterix by 219.1% in the fourth quarter. Tower Research Capital LLC TRC now owns 5,702 shares of the company’s stock worth $61,000 after purchasing an additional 3,915 shares during the last quarter. Finally, Envestnet Asset Management Inc. raised its stake in shares of Quanterix by 22.5% in the fourth quarter. Envestnet Asset Management Inc. now owns 342,264 shares of the company’s stock worth $3,638,000 after purchasing an additional 62,757 shares during the last quarter. Institutional investors and hedge funds own 86.48% of the company’s stock.

Quanterix Price Performance

Shares of NASDAQ:QTRX opened at $4.87 on Tuesday. Quanterix Co. has a 1 year low of $4.05 and a 1 year high of $19.18. The company has a market capitalization of $189.10 million, a PE ratio of -4.59 and a beta of 1.12. The business has a fifty day moving average price of $5.83 and a two-hundred day moving average price of $8.71.

Quanterix (NASDAQ:QTRX) last posted its quarterly earnings results on Monday, May 12th. The company reported ($0.53) earnings per share for the quarter, beating the consensus estimate of ($0.69) by $0.16. Quanterix had a negative net margin of 30.12% and a negative return on equity of 11.74%. The company had revenue of $30.33 million during the quarter, compared to analyst estimates of $28.27 million. Sell-side analysts anticipate that Quanterix Co. will post -0.98 earnings per share for the current year.

Analyst Ratings Changes

Several equities research analysts recently issued reports on QTRX shares. Canaccord Genuity Group decreased their price target on Quanterix from $15.00 to $12.00 and set a “buy” rating for the company in a report on Tuesday, May 13th. Scotiabank reaffirmed an “outperform” rating on shares of Quanterix in a report on Tuesday, March 25th. Leerink Partners reiterated a “market perform” rating and issued a $8.00 target price (down previously from $12.00) on shares of Quanterix in a report on Wednesday, April 30th. Finally, Leerink Partnrs lowered shares of Quanterix from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, April 30th. Three investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $15.60.

About Quanterix

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.